A rat model for stable chronic obstructive pulmonary disease induced by cigarette smoke inhalation and repetitive bacterial infection

Biological and Pharmaceutical Bulletin

Volumn 35, Issue 10, 2012, Pages 1752-1760

  Li, Ya ^a   Li, Su Yun ^a   Li, Jian Sheng ^a   Deng, Li ^a   Tian, Yan Ge ^a   Jiang, Su Li ^a   Wang, Ying ^a   Wang, Yuan Yuan ^a  

^a HENAN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Animal model; Chronic obstructive; Histological change; Pulmonary disease; Pulmonary function; Right ventricular hypertrophy index

Indexed keywords

CIGARETTE SMOKE; INTERLEUKIN 10; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BACTERIAL INFECTION; BRONCHIOLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FEMALE; HEART RIGHT VENTRICLE HYPERTROPHY; LUNG ALVEOLUS; LUNG LAVAGE; LUNG STRUCTURE; MALE; NONHUMAN; PEAK EXPIRATORY FLOW; PROTEIN EXPRESSION; RAT; SERUM; SPRAGUE DAWLEY RAT; TIDAL VOLUME;

ADMINISTRATION, INHALATION; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATORY FUNCTION TESTS; SMOKE; TOBACCO;

EID: 84867246689     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b12-00407     Document Type: Article

References (52)

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy of the diagnosis, management, and prevention of chronic obstructive pulmonary disease, revised 2011 (Online). "The Global Initiative for Chronic Obstructive Lung Disease.": 〈http://www.goldcopd.org/guidelines- global-strategy-for-diagnosis-management.html〉, Accessed 5 March, 2012.
2. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, Schmid V, Buist S. Chronic obstructive pulmonary disease: current burden and future projections. Eur. Respir. J., 27, 397-412 (2006).
3. Zhong N, Wang C, Yao W, Chen P, Kang J, Huang S, Chen B, Wang C, Ni D, Zhou Y, Liu S, Wang X, Wang D, Lu J, Zheng J, Ran P. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am. J. Respir. Crit. Care Med., 176, 753-760 (2007).
4. Li XJ, Li Q, Si LY, Yuan QY. Bacteriological differences between COPD exacerbation and community-acquired pneumonia. Respir. Care, 56, 1818-1824 (2011).
5. Bari MR, Hiron MM, Zaman SM, Rahman MM, Ganguly KC. Microbes responsible for acute exacerbation of COPD. Mymensingh Med. J., 19, 576-585 (2010).
6. Lin SH, Kuo PH, Hsueh PR, Yang PC, Kuo SH. Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa. Respirology, 12, 81-87 (2007).
7. Kościuch J, Chazan R. The role of viruses in the pathogenesis of obstructive lung diseases. Pol. Merkuriusz Lek., 15, 292-295 (2003).
8. Proud D, Chow CW. Role of viral infections in asthma and chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol., 35, 513-518 (2006).
9. Greenberg SB, Allen M, Wilson J, Atmar RL. Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 162, 167-173 (2000).
10. Rohde G, Wiethege A, Borg I, Kauth M, Bauer TT, Gillissen A, Bufe A, Schultze-Werninghaus G. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax, 58, 37-42 (2003).
11. Sikkel MB, Quint JK, Mallia P, Wedzicha JA, Johnston SL. Respiratory syncytial virus persistence in chronic obstructive pulmonary disease. Pediatr. Infect. Dis. J., 27, S63-S70 (2008).
12. Tantucci C, Modina D. Lung function decline in COPD. Int. J. Chron. Obstruct. Pulmon. Dis., 7, 95-99 (2012).
13. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Paré PD. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med., 350, 2645-2653 (2004).
14. Wright JL, Churg A. Cigarette smoke causes physiologic and morphologic changes of emphysema in the guinea pig. Am. Rev. Respir. Dis., 142, 1422-1428 (1990).
15. Xu H, Xiong M, Huang Q. The study on COPD rat model produced by bacterial infection. Zhonghua Jie He He Hu Xi Za Zhi, 22, 739-742 (1999).
16. Wright JL, Churg A. Animal models of cigarette smoke-induced chronic obstructive pulmonary disease. Expert Rev. Respir. Med., 4, 723-734 (2010).
17. Wagner U, Staats P, Fehmann HC, Fischer A, Welte T, Groneberg DA. Analysis of airway secretions in a model of sulfur dioxide induced chronic obstructive pulmonary disease (COPD). J. Occup. Med. Toxicol., 1, 12 (2006).
18. Xu J, Zhao M, Liao S. Establishment and pathological study of models of chronic obstructive pulmonary disease by SO2 inhalation method. Chin. Med. J. (Engl.), 113, 213-216 (2000).
19. Murǎrescu ED, Eloae-Zugun F, Mihailovici MS. Experimental COPD induced by solid combustible burn smoke in rats: a study of the emphysematous changes of the pulmonary parenchyma. Rom. J. Morphol. Embryol., 49, 495-505 (2008).
20. Christensen PJ, Preston AM, Ling T, Du M, Fields WB, Curtis JL, Beck JM. Pneumocystis murina infection and cigarette smoke exposure interact to cause increased organism burden, development of airspace enlargement, and pulmonary inflammation in mice. Infect. Immun., 76, 3481-3490 (2008).
21. Hardaker EL, Freeman MS, Dale N, Bahra P, Raza F, Banner KH, Poll C. Exposing rodents to a combination of tobacco smoke and lipopolysaccharide results in an exaggerated inflammatory response in the lung. Br. J. Pharmacol., 160, 1985-1996 (2010).
22. Seemungal TAR, Hurst JR, Wedzicha JA. Exacerbation rate, health status and mortality in COPD - a reiew of potential interventions. Int. J. Chron. Obstruct. Pulmon. Dis., 4, 203-223 (2009).
23. Li JS, Li SY, Wang YH. Reproduction of a murine model of chronic obstructive pulmonary disease with acute exacerbation. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 21, 682-684 (2009).
24. Wright JL, Churg A. A model of tobacco smoke-induced airflow obstruction in the guinea pig. Chest, 121, 188S-191S (2002).
25. Wright JL, Cosio M, Churg A. Animal models of chronic obstructive pulmonary disease. Am. J. Physiol. Lung Cell. Mol. Physiol., 295, L1-L15 (2008).
26. Liu ZB, Song NN, Geng WY, Jin WZ, Li L, Cao YX, Qian Y, Zhu DN, Shen LL. Orexin-A and respiration in a rat model of smoke-induced chronic obstructive pulmonary disease. Clin. Exp. Pharmacol. Physiol., 37, 963-968 (2010).
27. Hnizdo E. Lung function loss associated with occupational dust exposure in metal smelting. Am. J. Respir. Crit. Care Med., 181, 1162-1163 (2010).
28. Chakrabati B, Purkait S, Gun P, Moore VC, Choudburi S, Zaman MJ, Warburton CJ, Calverler PM, Mukherjee R. Chronic airflow limitation in a rural Italian population: etiology and relationship to body mass index. Int. J. Chronic Obstruct. Pulmon. Dis., 6, 6543-6549 (2011).
29. Engelen MP, Schols AM, Does JD, Wouters EF. Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am. J. Clin. Nutr., 71, 733-738 (2000).
30. Palange P, Forte S, Onorati P, Paravati V, Manfredi F, Serra P, Carlone S. Effect of reduced body weight on muscle aerobic capacity in patients with COPD. Chest, 114, 12-18 (1998).
31. Mostert R, Goris A, Weling-Scheepers C, Wouters EF, Schols AM. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir. Med., 94, 859-867 (2000).
32. Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 157, 1791-1797 (1998).
33. Gosker HR, Lencer NH, Franssen FM, van der Vusse GJ, Wouters EF, Schols AM. Striking similarities in systemic factors contributing to decreased exercise capacity in patients with severe chronic heart failure or COPD. Chest, 123, 1416-1424 (2003).
34. Wüst RCI, Degens H. Factors contributing to muscle wasting and dysfunction in COPD patients. Int. J. Chron. Obstruct. Pulmon. Dis., 2, 289-300 (2007).
35. Mizutani N, Fuchikami J, Takahashi M, Nabe T, Yoshino S, Kohno S. Development of cigarette smoke solution- and lipopolysaccharide-induced pulmonary emphysema in guinea pigs. Nippon Yakurigaku Zasshi, 135, 25-29 (2010).
36. Miller M, Pham A, Cho JY, Rosenthal P, Broide DH. Adiponectin-deficient mice are protected against tobacco-induced inflammation and increased emphysema. Am. J. Physiol. Lung Cell. Mol. Physiol., 299, L834-L842 (2010).
37. Ryter SW, Lee SJ, Choi AM. Autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. Expert Rev. Respir. Med., 4, 573-584 (2010).
38. Perez-Padilla R, Schilmann A, Riojas-Rodriguez H. Respiratory health effects of indoor air pollution. Int. J. Tuberc. Lung Dis., 14, 1079-1086 (2010).
39. Chapman RW. Canine models of asthma and COPD. Pulm. Pharmacol. Ther., 21, 731-742 (2008).
40. Shapiro SD. Animal models for COPD. Chest, 117, 223S-227S (2000).
41. Arunachalam G, Sundar IK, Hwang JW, Yao H, Rahman I. Emphysema is associated with increased inflammation in lungs of atherosclerosis-prone mice by cigarette smoke: implications in comorbidities of COPD. J. Inflamm. (London), 7, 34 (2010).
42. Churg A, Cosio M, Wright JL. Mechanisms of cigarette smoke-induced COPD: insights from animal models. Am. J. Physiol. Lung Cell. Mol. Physiol., 294, L612-L631 (2008).
43. Macario CC, Torres Tajes JP, Córdoba Lanus E. COPD: bronchial and systemic inflammation. Arch. Bronconeumol., 46, 9-15 (2010).
44. Wang T, Han SX, Zhang SF, Ning YY, Chen L, Chen YJ, He GM, Xu D, An J, Yang T, Zhang XH, Wen FQ. Role of chymase in cigarette smoke-induced pulmonary artery remodeling and pulmonary hypertension in hamsters. Respir. Res., 11, 36 (2010).
45. Andersen ZJ, Hvidberg M, Jensen SS, Ketzel M, Loft S, Sørensen M, Tjønneland A, Overvad K, Raaschou-Nielsen O. Chronic obstructive pulmonary disease and long-term exposure to traffic-related air pollution: a cohort study. Am. J. Respir. Crit. Care Med., 183, 455-461 (2011).
46. Hnizdo E, Yan T, Hakobyan A, Enright P, Beeckman-Wagner LA, Hankinson J, Fleming J, Lee Petsonk E. Spirometry longitudinal data analysis software (SPIROLA) for analysis of spirometry data in workplace prevention or COPD treatment. Open Med. Inform. J., 4, 94-102 (2010).
47. Kurmi OP, Semple S, Simkhada P, Smith WC, Ayres JG. COPD and chronic bronchitis risk of indoor air pollution from solid fuel: a systematic review and meta-analysis. Thorax, 65, 221-228 (2010).
48. Louhelainen N, Stark H, Mazur W, Rytilä P, Djukanovic R, Kinnula VL. Elevation of sputum matrix metalloproteinase-9 persists up to 6 months after smoking cessation: a research study. BMC Pulm. Med., 10, 13 (2010).
49. Morita H, Nagai R. MMP12, lung function, and COPD in high-risk populations. N. Engl. J. Med., 362, 1241-1242 (2010).
50. Baginski TK, Dabbagh K, Satjawatcharaphong C, Swinney DC. Cigarette smoke synergistically enhances respiratory mucin induction by proinflammatory stimuli. Am. J. Respir. Cell Mol. Biol., 35, 165-174 (2006).
51. Mizutani N, Fuchikami J, Takahashi M, Nabe T, Yoshino S, Kohno S. Pulmonary emphysema induced by cigarette smoke solution and lipopolysaccharide in guinea pigs. Biol. Pharm. Bull., 32, 1559-1564 (2009).
52. D'hulst AI, Vermaelen KY, Brusselle GG, Joos GF, Pauwels RA. Time course of cigarette smoke-induced pulmonary inflammation in mice. Eur. Respir. J., 26, 204-213 (2005).